Oryzon Genomics SA (ORY) — Strategic Asset Allocation Index

Oryzon Genomics SA (ORY) has a Strategic Asset Allocation Index of 0.7% as of June 2023. Strategic assets (PP&E of €545.97K plus long-term investments of €-) total €545.97K, measured against net assets of €78.54 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ORY equity to assets ratio to measure how much of total assets are equity-financed.